Viking Therapeutics, Inc.
- VKTX
- NASDAQ
- Biotechnology
- Metabolic/Endocrine Drugs
- Thyroid Receptor Agonist
$25.17
Today −8.04%Quote Oct 16, 2026, 08:00 PM UTC
−14.27%over the last month
Max drawdown −39.6%From 1-month high −39.6%3 months −30.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$3.20B
Quote Oct 16
Next earnings
Oct 28
Expected, not confirmed
Analyst target
$97.80
+288.6% from here
Floor
$23.85
5.2% below price
Where the price sits
24 analysts
Analyst range, low to high
$85.00$120.00
- Price $25.17
- Resistance $25.45
- Consensus $97.80
The price is right under resistance. Analysts' average target sits about 289% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VKTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
65
Founded
2012